Year-End Termination Amendment
ML STRATEGIES, LLC for MGI PHARMA INC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Firm
Client
Income
$40,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| Year-End Termination Amendment (this page) | Dec 5, 2007 | $40,000 | Replaced |
| Year-End Termination | Mar 9, 2009 | $40,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S. 1082 FDA Revitalization Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK BUSE | N/A |
| KENNETH CONNOLLY | STAFF DIRECTOR SENATE EPW COMMITTE |
| STEVEN IRIZARRY | — |
| DAVID LEITER | N/A |
| PATRICK D MARA | N/A |
| ROBERT NEAL MARTIN | N/A |
| JEREMY RABINOVITZ | CHIEF OF STAFF - CONGRESSWOMAN LOIS CAPPS |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.